Regeneron Pharmaceuticals Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with 70% of recent trades being bearish and 30% bullish. The trades have targeted a price range of $820.0 to $920.0 for Regeneron over the last 3 months. The current price of REGN is $818.04, with RSI indicators suggesting the stock may be approaching oversold. The next earnings are expected in 30 days.
October 03, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bearish stance taken on Regeneron Pharmaceuticals with majority of recent trades being bearish. The stock may be approaching oversold.
The bearish stance taken by a significant investor, along with the majority of recent trades being bearish, suggests a negative short-term impact on the stock. The RSI indicators also suggest that the stock may be approaching oversold, which could further drive down the price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100